Aim ImmunoTech Announces Positive Data From Ampligen Study In Combination With Pembrolizumab

(RTTNews) - Aim ImmunoTech Inc. (AIM) announced positive preliminary findings on Wednesday, showing that pairing Ampligen or rintatolimod with Key...

Related Keywords

Thomas Equels ,Immunotech Inc ,Objective Response Rate ,